Picture of Aptinyx logo

APTX — Aptinyx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Aptinyx Inc - Ended Q4 Of 2021 With About $106 Million In Cash And Cash Equivalents (Unaudited)

Jan 6 (Reuters) - Aptinyx Inc  APTX.O :
    * APTINYX INC - ENDED Q4 OF 2021 WITH ABOUT $106 MILLION IN
CASH
AND CASH EQUIVALENTS (UNAUDITED)
    * APTINYX INC - EXPECTS CURRENT CASH BALANCE, GUARANTEED
AVAILABLE
CASH TO FUND PHASE 2 READOUTS FROM EACH OF ONGOING DEVELOPMENT
PROGRAMS
    * APTINYX INC - EXPECTS CURRENT CASH BALANCE, GUARANTEED
AVAILABLE
CASH TO SUPPORT ANTICIPATED OPERATIONS INTO 2023
    * APTINYX INC - NYX-2925 FOR CHRONIC PAIN - PHASE 2B
READOUTS
EXPECTED IN 2Q AND MID-YEAR 2022
    * APTINYX INC - NYX-458FOR COGNITIVE IMPAIRMENT - PHASE 2
READOUT
EXPECTED IN 2H 2022
    * APTINYX INC - NYX-783 FOR PTSD - PHASE 2B READOUT EXPECTED
IN
2023

Source text for Eikon:  ID:nBw9PZmCVa 
Further company coverage:  APTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aptinyx

See all news